KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Cme (CME) over the last 17 years, with Q3 2025 value amounting to 0.15.

  • Cme's Equity Ratio fell 2643.73% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year decrease of 2643.73%. This contributed to the annual value of 0.19 for FY2024, which is 651.78% down from last year.
  • According to the latest figures from Q3 2025, Cme's Equity Ratio is 0.15, which was down 2643.73% from 0.15 recorded in Q2 2025.
  • Over the past 5 years, Cme's Equity Ratio peaked at 0.22 during Q3 2023, and registered a low of 0.13 during Q1 2022.
  • Over the past 5 years, Cme's median Equity Ratio value was 0.16 (recorded in 2023), while the average stood at 0.17.
  • As far as peak fluctuations go, Cme's Equity Ratio tumbled by 3453.25% in 2021, and later skyrocketed by 4156.65% in 2023.
  • Cme's Equity Ratio (Quarter) stood at 0.14 in 2021, then increased by 10.83% to 0.15 in 2022, then surged by 33.58% to 0.21 in 2023, then dropped by 6.52% to 0.19 in 2024, then fell by 21.83% to 0.15 in 2025.
  • Its Equity Ratio stands at 0.15 for Q3 2025, versus 0.15 for Q2 2025 and 0.17 for Q1 2025.